NVRO – Nevro Corp.
Nevro Corp.NVRO
$4.97Name : Nevro Corp.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $185,297,504.00
EPSttm : -2.12
Nevro Corp.
$4.97
0.40%$0.02Fair Value
Margin Of Safety %
Put/Call OI Ratio
2.71
Float Short %
8.32
EPS 1 Diff
-0.26
EPS Year Diff
-0.16
Ticker: NVRO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | NVRO | 5.17 | 2.69 | 0.01 | 19963 |
| 2024-09-09 | NVRO | 4.895 | 2.60 | 0.00 | 20149 |
| 2024-09-10 | NVRO | 4.84 | 2.60 | 0.00 | 20151 |
| 2024-09-11 | NVRO | 4.71 | 2.60 | 0.00 | 20151 |
| 2024-09-12 | NVRO | 5.1 | 2.59 | 0.13 | 20156 |
| 2024-09-13 | NVRO | 5.8 | 2.57 | 0.00 | 20199 |
| 2024-09-16 | NVRO | 5.77 | 2.57 | 33.33 | 20200 |
| 2024-09-17 | NVRO | 5.85 | 2.59 | 0.04 | 20302 |
| 2024-09-18 | NVRO | 5.82 | 2.57 | 0.00 | 20333 |
| 2024-09-19 | NVRO | 5.85 | 2.57 | 999.99 | 20341 |
| 2024-09-20 | NVRO | 5.85 | 2.57 | 0.88 | 20342 |
| 2024-09-23 | NVRO | 5.71 | 2.86 | 0.05 | 19489 |
| 2024-09-24 | NVRO | 5.73 | 2.82 | 0.00 | 19554 |
| 2024-09-25 | NVRO | 5.39 | 2.82 | 0.00 | 19554 |
| 2024-09-26 | NVRO | 5.4 | 2.81 | 0.10 | 19570 |
| 2024-09-27 | NVRO | 5.28 | 2.80 | 0.00 | 19592 |
| 2024-09-30 | NVRO | 5.59 | 2.79 | 0.00 | 19599 |
| 2024-10-01 | NVRO | 5.22 | 2.79 | 0.00 | 19599 |
| 2024-10-02 | NVRO | 5.14 | 2.78 | 0.00 | 19623 |
| 2024-10-03 | NVRO | 4.94 | 2.73 | 0.00 | 19719 |
| 2024-10-04 | NVRO | 4.96 | 2.71 | 0.00 | 19753 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | NVRO | 5.18 | -26.2 | - | -2.72 |
| 2024-09-09 | NVRO | 4.87 | -26.2 | - | -2.72 |
| 2024-09-10 | NVRO | 4.84 | -26.2 | - | -2.72 |
| 2024-09-11 | NVRO | 4.70 | -26.2 | - | -2.72 |
| 2024-09-12 | NVRO | 5.10 | -26.2 | - | -2.72 |
| 2024-09-13 | NVRO | 5.80 | -26.2 | - | -2.72 |
| 2024-09-16 | NVRO | 5.76 | -26.2 | - | -2.72 |
| 2024-09-17 | NVRO | 5.92 | -26.2 | - | -2.72 |
| 2024-09-18 | NVRO | 5.81 | -26.2 | - | -2.72 |
| 2024-09-19 | NVRO | 5.86 | -26.2 | - | -2.72 |
| 2024-09-20 | NVRO | 5.85 | -26.2 | - | -2.72 |
| 2024-09-23 | NVRO | 5.71 | -26.2 | - | -2.72 |
| 2024-09-24 | NVRO | 5.74 | -26.2 | - | -2.72 |
| 2024-09-25 | NVRO | 5.39 | -26.2 | - | -2.72 |
| 2024-09-26 | NVRO | 5.20 | -26.2 | - | -2.72 |
| 2024-09-27 | NVRO | 5.29 | -26.2 | - | -2.72 |
| 2024-09-30 | NVRO | 5.60 | -26.2 | - | -2.72 |
| 2024-10-01 | NVRO | 5.23 | -26.2 | - | -2.72 |
| 2024-10-02 | NVRO | 5.14 | -26.2 | - | -2.72 |
| 2024-10-03 | NVRO | 4.95 | -24.6 | - | -2.72 |
| 2024-10-04 | NVRO | 4.97 | -24.6 | - | -2.72 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | NVRO | 0.00 | -1.51 | 8.63 |
| 2024-09-09 | NVRO | 0.00 | -1.51 | 8.63 |
| 2024-09-10 | NVRO | 0.00 | -1.51 | 8.63 |
| 2024-09-11 | NVRO | 0.00 | -1.51 | 8.63 |
| 2024-09-12 | NVRO | 0.00 | -1.51 | 8.47 |
| 2024-09-13 | NVRO | 0.00 | -1.51 | 8.47 |
| 2024-09-16 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-17 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-18 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-19 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-20 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-23 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-24 | NVRO | 0.00 | -1.51 | 8.48 |
| 2024-09-25 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-09-26 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-09-27 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-09-30 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-10-01 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-10-02 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-10-03 | NVRO | 0.00 | -1.51 | 8.32 |
| 2024-10-04 | NVRO | 0.00 | -1.51 | 8.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.43
Avg. EPS Est. Current Quarter
-0.82
Avg. EPS Est. Next Quarter
-0.69
Insider Transactions
Institutional Transactions
-1.51
Beta
0.94
Average Sales Estimate Current Quarter
93
Average Sales Estimate Next Quarter
103
Fair Value (Academic)
Quality Score
45
Growth Score
39
Sentiment Score
19
Actual DrawDown %
97.4
Max Drawdown 5-Year %
-97.4
Target Price
7.41
P/E
Forward P/E
PEG
P/S
0.43
P/B
0.67
P/Free Cash Flow
EPS
-2.12
Average EPS Est. Cur. Y
-2.72
EPS Next Y. (Est.)
-2.6
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-18.18
Relative Volume
0.41
Return on Equity vs Sector %
-49.9
Return on Equity vs Industry %
-39.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
Nevro Corp.Sector: Healthcare
Industry: Medical Devices
Employees: 1215
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
stock quote shares NVRO – Nevro Corp. Stock Price stock today
news today NVRO – Nevro Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVRO – Nevro Corp. yahoo finance google finance
stock history NVRO – Nevro Corp. invest stock market
stock prices NVRO premarket after hours
ticker NVRO fair value insiders trading